Literature DB >> 31269814

Natural History of Myocardial Injury and Chamber Remodeling in Acute Myocarditis.

James A White1,2,3,4, Reis Hansen1, Ahmed Abdelhaleem1, Yoko Mikami1, Mingkai Peng5, Sandra Rivest1, Alessandro Satriano1, Steven Dykstra1, Jacqueline Flewitt1, Bobak Heydari1,3,4, Carmen P Lydell1,2,3, Matthias G Friedrich5, Andrew G Howarth1,4.   

Abstract

BACKGROUND: Cardiovascular magnetic resonance (CMR) imaging is commonly used to diagnose acute myocarditis. However, the natural history of CMR-based tissue markers and their association with left ventricular recovery is poorly explored. We prospectively investigated the natural history of CMR-based myocardial injury and chamber remodeling over 12 months in patients with suspected acute myocarditis.
METHODS: One hundred patients with suspected acute myocarditis were enrolled. All underwent CMR evaluations at baseline and 12 months, inclusive of T2 and late gadolinium enhancement. Blinded quantitative analyses compared left ventricular chamber volumes, function, myocardial edema, and necrosis at each time point using predefined criteria. The predefined primary outcomes were improvement in left ventricular ejection fraction ≥10% and improvement in the indexed left ventricular end diastolic volume ≥10% at 12 months.
RESULTS: The mean age was 39.9±14.5 years (82 male) with baseline left ventricular ejection fraction of 57.1±11.2%. A total of 72 patients (72%) showed late gadolinium enhancement at baseline with 57 (57%) having any T2 signal elevation. Left ventricular volumes and EF improved significantly at 12 months. Global late gadolinium enhancement extent dropped from 8.5±9.2% of left ventricular mass to 3.0±5.2% ( P=0.0001) with prevalence of any late gadolinium enhancement dropping to 48%. Reductions in global T2 signal ratio occurred at 12 months (1.85±0.3 to 1.56±0.2; P=0.0001) with prevalence of T2 ratio ≥2.0 dropping to 7%. Neither marker provided associations with the primary outcomes.
CONCLUSIONS: In clinically suspected acute myocarditis, significant reductions in tissue injury markers occur during the first 12 months of convalescence. Neither the presence nor extent of the investigated CMR-based tissue injury markers were predictive of our pre-defined function or remodeling outcomes at 12 months in this referral population.

Entities:  

Keywords:  T2 weighted imaging; convalescence; fibrosis; magnetic resonance imaging; myocarditis

Mesh:

Substances:

Year:  2019        PMID: 31269814     DOI: 10.1161/CIRCIMAGING.118.008614

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  5 in total

1.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

2.  Clinical and Cardiovascular Magnetic Resonance Predictors of Early and Long-Term Clinical Outcome in Acute Myocarditis.

Authors:  Yohann Bohbot; Jérôme Garot; Thomas Hovasse; Thierry Unterseeh; Chloé Di Lena; Wahiba Boukefoussa; Chloé Tawa; Cédric Renard; Isabelle Limouzineau; Suzanne Duhamel; Philippe Garot; Christophe Tribouilloy; Francesca Sanguineti
Journal:  Front Cardiovasc Med       Date:  2022-04-29

3.  Natural History of Myocardial Injury After COVID-19 Vaccine-Associated Myocarditis.

Authors:  Muhammad Mustafa Alhussein; Mohamad Rabbani; Bradley Sarak; Steven Dykstra; Dina Labib; Jacqueline Flewitt; Carmen P Lydell; Andrew G Howarth; Neil Filipchuck; Angela Kealey; Jillian Colbert; Nita Guron; Louis Kolman; Naeem Merchant; Murad Bandali; Mike Bristow; James A White
Journal:  Can J Cardiol       Date:  2022-08-06       Impact factor: 6.614

Review 4.  [Cardiac magnetic resonance imaging : Trends and developments].

Authors:  A Mayr; G Reiter; D Beitzke
Journal:  Radiologe       Date:  2020-12       Impact factor: 0.635

5.  Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

Authors:  Enrico Ammirati; Maria Frigerio; Leslie T Cooper; Paolo G Camici; Eric D Adler; Cristina Basso; David H Birnie; Michela Brambatti; Matthias G Friedrich; Karin Klingel; Jukka Lehtonen; Javid J Moslehi; Patrizia Pedrotti; Ornella E Rimoldi; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circ Heart Fail       Date:  2020-11-12       Impact factor: 8.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.